Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „shows“
Suchtreffer
Begriffe & Kennungen
Pradaxa · 4.8 · Table 12 shows the adverse reactions identified from studies and post-marketing data in the indications primar
Eintrag öffnenPradaxa · 4.8 · Table 12 shows the adverse reactions identified from the studies in the treatment of VTE and prevention of rec
Eintrag öffnenPradaxa · 4.8 · Table 13 shows bleeding events in the pooled pivotal studies RE-COVER and RE-COVER II testing the treatment of
Eintrag öffnenPradaxa · 4.8 · Table 15 shows bleeding events in pivotal study RE-SONATE testing prevention of DVT and PE. The rate of the co
Eintrag öffnenPradaxa · 4.8 · Table 15 shows bleeding events in the pooled pivotal studies RE-COVER and RE-COVER II testing the treatment of
Eintrag öffnenPradaxa · 4.8 · Table 16 shows bleeding events in pivotal study RE-MEDY testing prevention of DVT and PE. Some bleeding events
Eintrag öffnenPradaxa · 4.8 · Table 16 shows the adverse reactions identified from the studies in the treatment of VTE and prevention of rec
Eintrag öffnenPradaxa · 4.8 · Table 17 shows bleeding events in pivotal study RE-SONATE testing prevention of DVT and PE. The rate of the co
Eintrag öffnenPradaxa · 4.8 · Table 18 shows the adverse reactions identified from the studies in the treatment of VTE and prevention of rec
Eintrag öffnenPradaxa · 4.8 · Table 8 shows the adverse reactions identified from the studies in the treatment of VTE and prevention of recu
Eintrag öffnenPradaxa · 4.8 · The table 11 shows the number (%) of patients experiencing the adverse reaction bleeding during the treatment
Eintrag öffnenPradaxa · 4.8 · The table 12 shows bleeding events broken down to major and any bleeding in the pivotal study testing the prev
Eintrag öffnenPradaxa · 4.8 · The table 13 shows the number (%) of patients experiencing the adverse reaction bleeding during the treatment
Eintrag öffnenPradaxa · 4.8 · The table 14 shows bleeding events broken down to major and any bleeding in the pivotal study testing the prev
Eintrag öffnenPrialt · 4.8 · Tabulated list of adverse reactions Unless otherwise noted the table shows the incidence rates of adverse reac
Eintrag öffnenPrialt · 4.8 · Tabulated list of adverse reactions Unless otherwise noted the table shows the incidence rates of adverse reac
Eintrag öffnenPrivigen · 4.8 · The following table shows an overview of the ADRs observed in the seven clinical studies categorized according
Eintrag öffnenPrometax · 4.8 · 22 Table 2 shows the adverse reactions reported in patients with dementia associated with Parkinson’s disease
Eintrag öffnenPrometax · 4.8 · Table 2 shows the adverse reactions reported in patients with dementia associated with Parkinson’s disease tre
Eintrag öffnenQuviviq · 4.8 · Table 1 shows adverse reactions that occurred in Study 1 and Study 2 or in post-marketing experience.
Eintrag öffnen